Insider Transactions in Q2 2023 at Relmada Therapeutics, Inc. (RLMD)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2023
|
Cedric O'Gorman Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+49.7%
|
$30,000
$3.18 P/Share
|